Immunogenicity and safety of 4 vs. 3 standard doses of HBV vaccination in HIV-infected adults with isolated anti-HBc antibody

Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: Results of a prospective Italian study

(2017) Giulia Morsica et al.   PLoS One

Vaccination Against Hepatitis B Virus (HBV) in HIV-1–Infected Patients With Isolated Anti–HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective Study

(2016) Lionel Piroth et al.   JOURNAL OF INFECTIOUS DISEASES

CD4/CD8 ratio as a predictor of the response to HBV vaccination in HIV-positive patients: A prospective cohort study

(2016) Francisco Fuster et al.   VACCINE

Factors influencing immunologic response to hepatitis B vaccine in adults

(2016) Shigui Yang et al.   Scientific Reports

Factors Associated With Seroconversion After Standard Dose Hepatitis B Vaccination and High-Dose Revaccination Among HIV-Infected Patients

(2014) Natasha N. Pettit et al.   HIV CLINICAL TRIALS

Spontaneous reactivation of hepatitis B virus replication in an HIV coinfected patient with isolated anti-Hepatitis B core antibodies

(2014) Rongjuan Pei et al.   Virology Journal

Isolated Anti-HBc Among HIV-Infected Patients in Istanbul, Turkey

(2013) Hayat Kumbasar Karaosmanoglu et al.   HIV CLINICAL TRIALS

Comparison of Immunogenicity and Safety of Four Doses and Four Double Doses vs. Standard Doses of Hepatitis B Vaccination in HIV-Infected Adults: A Randomized, Controlled Trial

(2013) Kanokporn Chaiklang et al.   PLoS One

Predictors of the Isolated Hepatitis B Core Antibody Pattern in HIV-Infected and -Uninfected Men in the Multicenter AIDS Cohort Study

(2012) Mallory D. Witt et al.   CLINICAL INFECTIOUS DISEASES

Immune response to hepatitis B vaccination in HIV-positive adults with isolated antibodies to HBV core antigen

(2012) Chloe Kaech et al.   JOURNAL OF INFECTION

Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults

(2012) D.V. Potsch et al.   VACCINE

Safety and Immunogenicity of 4 Intramuscular Double Doses and 4 Intradermal Low Doses vs Standard Hepatitis B Vaccine Regimen in Adults With HIV-1

(2011) Odile Launay   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Serologic Response to Hepatitis B Vaccination in HIV‐Infected Patients with Isolated Positivity for Antibodies to Hepatitis B Core Antigen

(2010) Catherine Chakvetadze et al.   CLINICAL INFECTIOUS DISEASES

Nadir CD4 T Cell Count as Predictor and High CD4 T Cell Intrinsic Apoptosis as Final Mechanism of Poor CD4 T Cell Recovery in Virologically Suppressed HIV‐Infected Patients: Clinical Implications

(2010) Eugènia Negredo et al.   CLINICAL INFECTIOUS DISEASES

Effect of Baseline HIV Disease Parameters on CD4+ T Cell Recovery After Antiretroviral Therapy Initiation in Kenyan Women

(2010) Lyle R. McKinnon et al.   PLoS One

Hepatitis B vaccination in HIV-infected adults: current evidence, recommendations and practical considerations

(2009) H N Kim et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: Another benefit of HAART in those with preserved CD4 count

(2009) Michael L. Landrum et al.   VACCINE

European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults

(2008) JK Rockstroh et al.   HIV MEDICINE

Occult Hepatitis B Virus Infection in HIV-Infected Patients with Isolated Hepatitis B Core Antibody

(2008) Kayhan Azadmanesh et al.   INTERVIROLOGY